Histone deacetylase — Drug Target

All drugs that target Histone deacetylase — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Histone deacetylase inhibitor

Marketed (1)

• HG-group · Medical University of Vienna · Histone deacetylase inhibitor · Oncology
  HG-group is a histone deacetylase inhibitor.

Phase 3 pipeline (2)

• TCbHP VS ddEC-THP · Tianjin Medical University Cancer Institute and Hospital · Histone deacetylase inhibitor · Oncology
  TCbHP is a histone deacetylase inhibitor, which works by blocking the activity of histone deacetylases to modify gene expression.
• TLK286 in Combination with Carboplatin · Telik · Histone deacetylase inhibitor · Oncology
  TLK286 is a histone deacetylase inhibitor that works by blocking the activity of histone deacetylases, leading to the inhibition of cancer cell growth and induction of apoptosis.

Phase 2 pipeline (3)

• CC-2001 · Celgene · Histone deacetylase inhibitor · Oncology
  CC-2001 is a histone deacetylase inhibitor.
• Aplidin® · PharmaMar · Histone deacetylase inhibitor · Oncology
  Aplidin is a chemotherapeutic agent that works by inhibiting the enzyme histone deacetylase (HDAC).
• HDAC inhibitor SB939 · NCIC Clinical Trials Group · Histone deacetylase inhibitor · Oncology
  Histone deacetylase inhibitor